These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 16551628)
1. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. Reddy MA; Li SL; Sahar S; Kim YS; Xu ZG; Lanting L; Natarajan R J Biol Chem; 2006 May; 281(19):13685-13693. PubMed ID: 16551628 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line. Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983 [TBL] [Abstract][Full Text] [Related]
3. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis. Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Figarola JL; Shanmugam N; Natarajan R; Rahbar S Diabetes; 2007 Mar; 56(3):647-55. PubMed ID: 17327432 [TBL] [Abstract][Full Text] [Related]
5. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Shaw SS; Schmidt AM; Banes AK; Wang X; Stern DM; Marrero MB Diabetes; 2003 Sep; 52(9):2381-8. PubMed ID: 12941779 [TBL] [Abstract][Full Text] [Related]
6. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. Shanmugam N; Kim YS; Lanting L; Natarajan R J Biol Chem; 2003 Sep; 278(37):34834-44. PubMed ID: 12837757 [TBL] [Abstract][Full Text] [Related]
7. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling. Singh NK; Wang D; Kundumani-Sridharan V; Van Quyen D; Niu J; Rao GN J Biol Chem; 2011 Jun; 286(25):22478-88. PubMed ID: 21536676 [TBL] [Abstract][Full Text] [Related]
8. Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation. Meng L; Park J; Cai Q; Lanting L; Reddy MA; Natarajan R Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H736-45. PubMed ID: 20008269 [TBL] [Abstract][Full Text] [Related]
9. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. Bianchi R; Kastrisianaki E; Giambanco I; Donato R J Biol Chem; 2011 Mar; 286(9):7214-26. PubMed ID: 21209080 [TBL] [Abstract][Full Text] [Related]
10. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells. Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999 [TBL] [Abstract][Full Text] [Related]
11. RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes. Perrone L; Peluso G; Melone MA J Cell Physiol; 2008 Oct; 217(1):60-71. PubMed ID: 18452184 [TBL] [Abstract][Full Text] [Related]
12. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction. Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580 [TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes. Rasheed Z; Akhtar N; Haqqi TM Rheumatology (Oxford); 2011 May; 50(5):838-51. PubMed ID: 21172926 [TBL] [Abstract][Full Text] [Related]
14. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Sorci G; Riuzzi F; Agneletti AL; Marchetti C; Donato R Mol Cell Biol; 2003 Jul; 23(14):4870-81. PubMed ID: 12832473 [TBL] [Abstract][Full Text] [Related]
15. Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes. Kumar P; Raghavan S; Shanmugam G; Shanmugam N Metabolism; 2013 Aug; 62(8):1149-58. PubMed ID: 23523156 [TBL] [Abstract][Full Text] [Related]
16. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Sorci G; Riuzzi F; Arcuri C; Giambanco I; Donato R Mol Cell Biol; 2004 Jun; 24(11):4880-94. PubMed ID: 15143181 [TBL] [Abstract][Full Text] [Related]
17. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hattori Y; Suzuki M; Hattori S; Kasai K Hypertension; 2002 Jan; 39(1):22-8. PubMed ID: 11799073 [TBL] [Abstract][Full Text] [Related]
18. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Loeser RF; Yammani RR; Carlson CS; Chen H; Cole A; Im HJ; Bursch LS; Yan SD Arthritis Rheum; 2005 Aug; 52(8):2376-85. PubMed ID: 16052547 [TBL] [Abstract][Full Text] [Related]
19. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787 [TBL] [Abstract][Full Text] [Related]
20. RAGE mediates β-catenin stabilization via activation of the Src/p-Cav-1 axis in a chemical-induced asthma model. Zhao W; Lin Y; Xiong J; Wang Y; Huang G; Deng Q; Yao L; Yu C; Dong H; Cai S; Zhao H Toxicol Lett; 2018 Dec; 299():149-158. PubMed ID: 30261222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]